Clinical Trial Update: A Study of Ustekinumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease [Phase 3]

View source ↗

Summary

A Phase 3 pediatric trial evaluating ustekinumab for moderately to severely active Crohn's disease has been completed. The study was conducted by Janssen Resear…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• Stelara (ustekinumab)

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Crohn Disease | Phase 3 | Status: COMPLETED